We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Louisiana-Pacific
LPX
$5.15B
| $12.7M | 0.02% |
426,591
-5,468
| -1% | -$154K |
|
|
NUVA
702
DELISTED
NuVasive, Inc.
NUVA
| $12.6M | 0.02% |
163,444
-3,322
| -2% | -$235K |
|
703
First Horizon
FHN
$12.2B
| $12.6M | 0.02% |
763,139
-6,206
| -0.8% | -$101K |
|
|
SRC
704
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $12.6M | 0.02% |
256,929
+26,271
| +11% | +$1.31M |
|
705
Travel + Leisure Co
TNL
$4.72B
| $12.6M | 0.02% |
244,332
-6,655
| -3% | -$319K |
|
|
FLIR
706
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $12.6M | 0.02% |
242,459
+17,520
| +8% | +$927K |
|
707
Webster Financial
WBS
$12.6B
| $12.6M | 0.02% |
236,456
-15
| -0% | -$722 |
|
708
Hancock Whitney
HWC
$6.26B
| $12.6M | 0.02% |
287,448
-1,239
| -0.4% | -$50.2K |
|
709
Pentair
PNR
$10.7B
| $12.6M | 0.02% |
274,459
+19,374
| +8% | +$818K |
|
|
PRSP
710
DELISTED
Perspecta Inc. Common Stock
PRSP
| $12.6M | 0.02% |
475,104
+20,762
| +5% | +$553K |
|
711
Pebblebrook Hotel Trust
PEB
$2.18B
| $12.5M | 0.02% |
465,943
+9,049
| +2% | +$239K |
|
|
JBGS
712
JBG SMITH
JBGS
$829M
| $12.5M | 0.02% |
312,950
-3,994
| -1% | -$158K |
|
|
SYNH
713
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $12.5M | 0.02% |
209,488
+5,084
| +2% | +$273K |
|
|
NLSN
714
DELISTED
Nielsen Holdings plc
NLSN
| $12.4M | 0.02% |
611,903
+47,347
| +8% | +$962K |
|
715
Selective Insurance
SIGI
$5.69B
| $12.4M | 0.02% |
190,176
-3,301
| -2% | -$228K |
|
716
Simpson Manufacturing
SSD
$7.91B
| $12.4M | 0.02% |
154,436
+8,332
| +6% | +$649K |
|
717
Blackbaud
BLKB
$2.01B
| $12.4M | 0.02% |
155,300
+2,129
| +1% | +$178K |
|
718
Flowserve
FLS
$9.78B
| $12.3M | 0.02% |
246,174
+16,215
| +7% | +$776K |
|
719
MasTec
MTZ
$21B
| $12.2M | 0.02% |
190,884
+9,447
| +5% | +$622K |
|
720
Alnylam Pharmaceuticals
ALNY
$29.5B
| $12.2M | 0.02% |
106,105
+3,059
| +3% | +$305K |
|
721
Agree Realty
ADC
$9.24B
| $12.2M | 0.02% |
173,464
+13,441
| +8% | +$992K |
|
|
COR
722
DELISTED
Coresite Realty Corporation
COR
| $12.1M | 0.02% |
108,224
+5,330
| +5% | +$616K |
|
723
AGCO
AGCO
$7.28B
| $12.1M | 0.02% |
156,323
+2,971
| +2% | +$228K |
|
724
Ashland
ASH
$3.29B
| $12M | 0.02% |
157,018
+29
| +0% | +$2.2K |
|
725
Murphy USA
MUSA
$10.9B
| $12M | 0.02% |
102,264
+1,963
| +2% | +$212K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.